首页> 外文期刊>Nutrition Journal >Probiotics, prebiotics infant formula use in preterm or low birth weight infants: a systematic review
【24h】

Probiotics, prebiotics infant formula use in preterm or low birth weight infants: a systematic review

机译:益生菌,益生元婴儿配方奶粉在早产或低出生体重婴儿中的应用:系统综述

获取原文
           

摘要

Background Previous reviews (2005 to 2009) on preterm infants given probiotics or prebiotics with breast milk or mixed feeds focused on prevention of Necrotizing Enterocolitis, sepsis and diarrhea. This review assessed if probiotics, prebiotics led to improved growth and clinical outcomes in formula fed preterm infants. Methods Cochrane methodology was followed using randomized controlled trials (RCTs) which compared preterm formula containing probiotic(s) or prebiotic(s) to conventional preterm formula in preterm infants. The mean difference (MD) and corresponding 95% confidence intervals (CI) were reported for continuous outcomes, risk ratio (RR) and corresponding 95% CI for dichotomous outcomes. Heterogeneity was assessed by visual inspection of forest plots and a chi2 test. An I2 test assessed inconsistencies across studies. I2> 50% represented substantial heterogeneity. Results Four probiotics studies (N=212), 4 prebiotics studies (N=126) were included. Probiotics: There were no significant differences in weight gain (MD 1.96, 95% CI: -2.64 to 6.56, 2 studies, n=34) or in maximal enteral feed (MD 35.20, 95% CI: -7.61 to 78.02, 2 studies, n=34), number of stools per day increased significantly in probiotic group (MD 1.60, 95% CI: 1.20 to 2.00, 1 study, n=20). Prebiotics: Galacto-oligosaccharide / Fructo-oligosaccharide (GOS/FOS) yielded no significant difference in weight gain (MD 0.04, 95% CI: -2.65 to 2.73, 2 studies, n=50), GOS/FOS yielded no significant differences in length gain (MD 0.01, 95% CI: -0.03 to 0.04, 2 studies, n=50). There were no significant differences in head growth (MD ?0.01, 95% CI: -0.02 to 0.00, 2 studies, n=76) or age at full enteral feed (MD ?0.79, 95% CI: -2.20 to 0.61, 2 studies, n=86). Stool frequency increased significantly in prebiotic group (MD 0.80, 95% CI: 0.48 to 1.1, 2 studies, n=86). GOS/FOS and FOS yielded higher bifidobacteria counts in prebiotics group (MD 2.10, 95% CI: 0.96 to 3.24, n=27) and (MD 0.48, 95% CI: 0.28 to 0.68, n=56). Conclusions There is not enough evidence to state that supplementation with probiotics or prebiotics results in improved growth and clinical outcomes in exclusively formula fed preterm infants.
机译:背景先前的评论(2005年至2009年)是关于给予益生菌或益生元和母乳或混合喂养的早产儿的,重点是预防坏死性小肠结肠炎,败血症和腹泻。该评价评估了益生菌,益生元是否能改善配方奶粉喂养的早产儿的生长和临床结局。方法采用Cochrane方法进行随机对照试验(RCT),该试验将早产儿中含有益生菌或益生元的早产儿配方与常规早产儿进行了比较。报告了连续结果的平均差异(MD)和相应的95%置信区间(CI),二分结果报告了风险比(RR)和相应的95%CI。异质性通过目视检查林地和进行chi2评估来评估。 I2测试评估了研究之间的不一致。 I 2> 50%表示存在很大的异质性。结果包括4项益生菌研究(N = 212),4项益生菌研究(N = 126)。益生菌:体重增加(MD 1.96,95%CI:-2.64至6.56,2个研究,n = 34)或最大肠内喂养(MD 35.20,95%CI:-7.61至78.02,2个研究)无显着差异,n = 34),益生菌组每天的粪便数量显着增加(MD 1.60,95%CI:1.20至2.00,1个研究,n = 20)。益生元:低聚半乳糖/低聚果糖(GOS / FOS)在体重增加方面无显着差异(MD 0.04,95%CI:-2.65至2.73,2个研究,n = 50),GOS / FOS在体重增加方面无显着差异。长度增加(MD 0.01,95%CI:-0.03至0.04,2个研究,n = 50)。完全肠内喂养时的头部生长(MD≥0.01,95%CI:-0.02至0.00,2个研究,n = 76)或年龄均无显着差异(MD≥0.79,95%CI:-2.20至0.61,2。研究,n = 86)。益生元组的粪便频率显着增加(MD 0.80,95%CI:0.48至1.1,2个研究,n = 86)。在益生元组中,GOS / FOS和FOS产生更高的双歧杆菌计数(MD 2.10,95%CI:0.96至3.24,n = 27)和(MD 0.48,95%CI:0.28至0.68,n = 56)。结论尚无足够的证据表明补充益生菌或益生元可以改善纯配方奶粉喂养的早产儿的生长和临床效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号